Giuseppe Lamberti

5.3k citations
164 papers · 3.8k · 4 hit papers · h-index 32

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations

Papers in

    • Lung Cancer Research Studies 45
    • Cancer Immunotherapy and Biomarkers 31
    • Pancreatic and Hepatic Oncology Research 8
    • Neuroendocrine Tumor Research Advances 50

Giuseppe Lamberti

155 papers receiving 3.8k citations

Giuseppe Lamberti's Hit Papers

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer 2024 · 89 citations
890+1+3Years since publication50100150200250

Peers

Giuseppe Lamberti
Comparison fields: 5 of 107
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 897
  • Cancer Research 317
  • Epidemiology 703
  • Neurology 311
Replace Asim Amin with:
Asim Amin United States
Edurne Arriola Spain
Satya Das United States
Hisatsugu Goto Japan
W. J. Mooi Netherlands
Jhingook Kim South Korea
C. Boutros France
Johannes V. van Thienen Netherlands
Carl Zuelke Germany
Matthew Joseph Bott United States
Giuseppe Lamberti relative to Asim Amin United States Asim Amin's profile →
Citations per field
00.5×2×3.1×
Asim Amin · 1×
Citations per year

Countries citing papers authored by Giuseppe Lamberti

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Lamberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Lamberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Lamberti more than expected).

Fields of papers citing papers by Giuseppe Lamberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Lamberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Lamberti. The network helps show where Giuseppe Lamberti may publish in the future.

Co-authors

The 25 scholars most cited alongside Giuseppe Lamberti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Giuseppe Lamberti Line = papers co-authored together Giuseppe Lamberti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
Hit paper breakdown →
2021290
2
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Hit paper breakdown →
2022269
3 2020172
4 2019159
5
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Hit paper breakdown →
2023139
6 2021130
7 2020119
8 2020118
9
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer
Hit paper breakdown →
202489
10 202083
11 202277
12 201976
13 202373
14 201860
15 202460
16 202152
17 202051
18 202251
19 201949
20 202248

About Giuseppe Lamberti

Giuseppe Lamberti is a scholar working on Oncology, Epidemiology, Neurology, Pulmonary and Respiratory Medicine and Genetics, having authored 164 papers that have together received 3.8k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (50 papers), Lung Cancer Research Studies (45 papers), Cancer Immunotherapy and Biomarkers (31 papers), Lung Cancer Treatments and Mutations (22 papers), Neuroblastoma Research and Treatments (16 papers), Glioma Diagnosis and Treatment (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (897 citations), Cancer Research (317 citations), Epidemiology (703 citations) and Neurology (311 citations). Giuseppe Lamberti has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Davide Campana, Elisa Andrini, Biagio Ricciuti, Andrea Ardizzoni, Francesco Gelsomino, Alessandro Di Federico, Lisa Manuzzi, Mark Magdi Awad, Claudia Parisi and Adolfo Sebastiani. Their work appears in journals such as Annals of Oncology, Journal of Clinical Medicine, Journal of Thoracic Oncology, Cancers and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact